“We are grateful to the support of these partners, who share a common interest in the improved management diabetes,” said Anna Norton, MS, CEO of DiabetesSisters.
CHICAGO (PRWEB) January 14, 2020
DiabetesSisters is pleased to announce its 2020 National Strategic Partners - Amarin, AstraZeneca, Dexcom, Insulet, Janssen, Lilly, and Sanofi. Established in 2018 to collaborate with industry partners, the National Strategic Partnership focuses on needs in the diabetes community and facilitates open conversations between patients and industry partners to create relevant and valuable programs and services.
National Strategic Partners collaborate with DiabetesSisters’ Board of Directors and staff to discuss mutual-interest initiatives; offer ways to better inform the diabetes community of products, services, and assistance programs; and provide patient voices to industry to aid in the understanding of patient needs.
“We are grateful to the support of these partners, who share a common interest in the improved management diabetes,” said Anna Norton, MS, CEO of DiabetesSisters. “Their commitment to the physical and mental well-being of people with diabetes is evident in this partnership.”
A 501(c)3 nonprofit, DiabetesSisters is the only organization nationwide focusing exclusively on women living with diabetes. Our mission is to improve the health and quality of life of women living with and at risk of developing diabetes and to advocate on their behalf. DiabetesSisters has a nearly 50,000-member peer network that unites women with diabetes for the purpose of support, education, and advocacy. Signature programs include monthly peer support meetings (PODS Meetups); the Minority Initiative Program; Annual Leadership Institute for volunteer leaders; online expert articles, blog posts, forums; and conference. For more information, visit http://www.diabetessisters.org.